Delivery Order SPE2DB25D7067-SPE2DB25FSVWF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhalers (60-count) on September 2, 2025, with ultimate completion by September 3, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a small-value transaction typical of routine pharmaceutical supply replenishment orders. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,374.92 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count), with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.67 to AmerisourceBergen Drug Corp for Wixela 250-50 inhaler (60-count), a combination pharmaceutical product. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, operates under firm fixed-price terms with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wixela 500-50 inhaler, 60-count units, with a ceiling value of $2,009.59. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is scheduled for ultimate completion by October 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,022.88 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalation powder (60 doses), a combination pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed on August 27, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,743.18 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S pharmaceutical products. This non-competitive, firm fixed-price delivery order was awarded on September 8, 2025, with a completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $10,386.94 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Wixela 250-50 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of September 11, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,141.04 delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, which is a child order under a larger contract vehicle, involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. WIXELA is a combination inhalation medication used in respiratory therapy, reflecting...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVWFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler units (60-count) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was made without a set-aside designation, and performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and repeated awardee demonstrates its capability to meet federal procurement requirements through open competition across diverse product categories and transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/10/25 |